Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
3.200
+0.130 (4.23%)
Oct 20, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $118.98 million as of October 20, 2026. It is the 24,042nd most valuable company in the world and the 3,966th biggest in the United States. Its market cap has decreased by 3.41% in one year.
Market Cap
118.98M
Enterprise Value
408.98M
1-Year Change
-3.41%
Global Rank
Country Rank
#3,966 United States
Category
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $118.98M, an increase of 156.90%. That is a compound annual growth rate of 13.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 118.98M | -47.96% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 127.49M |
| Korro Bio | 126.75M |
| Cue Biopharma | 124.44M |
| Outlook Therapeutics | 124.26M |
| AN2 Therapeutics | 124.15M |
| Spruce Biosciences | 116.89M |
| NRx Pharmaceuticals | 115.94M |
| Humacyte | 112.40M |